Author

Patrice Pancza

Institution: Children's Tumor Foundation

Observed institution: Children's Tumor Foundation

ORCID: 0000-0003-0405-9993

Observed ORCID: 0000-0003-0405-9993

OpenAlex ID: A5020282896

Revised diagnostic criteria for neurofibromatosis type 1 and Legius syndrome: an international consensus recommendation

2021 · Eric Legius, Ludwine Messiaen, et al. · Genetics in Medicine · 921

Updated diagnostic criteria and nomenclature for neurofibromatosis type 2 and schwannomatosis: An international consensus recommendation

2022 · Scott R. Plotkin, Ludwine Messiaen, et al. · Genetics in Medicine · 317

Revised diagnostic criteria and nomenclature for neurofibromatosis 2 and schwannomatosis: an international consensus recommendation (S27.003)

2022 · Scott Plotkin, Ludwine Messiaen, et al. · Neurology · 18

Neurofibromatosis as a gateway to better treatment for a variety of malignancies

2016 · Annette C. Bakker, Salvatore La Rosa, et al. · Progress in Neurobiology · 9

Revised diagnostic criteria for neurofibromatosis type 1 and Legius syndrome: an international consensus recommendation (S27.002)

2022 · Scott Plotkin, Ludwine Messiaen, et al. · Neurology · 4

Abstract A32: Gaps and opportunities for RASopathies: Use of new tools to make the right choice in target and compound selection

2014 · Salvatore La Rosa, Pamela Knight, et al. · Molecular Cancer Research

Works count: 6

Citation count: 1,269

H-index: 4

I10-index: 3